NO934721L - Hemmere av HIV-protease som er nyttige for behandling av AIDS - Google Patents

Hemmere av HIV-protease som er nyttige for behandling av AIDS

Info

Publication number
NO934721L
NO934721L NO934721A NO934721A NO934721L NO 934721 L NO934721 L NO 934721L NO 934721 A NO934721 A NO 934721A NO 934721 A NO934721 A NO 934721A NO 934721 L NO934721 L NO 934721L
Authority
NO
Norway
Prior art keywords
alkyl
heterocycle
aids
inhibitors
treatment
Prior art date
Application number
NO934721A
Other languages
English (en)
Other versions
NO934721D0 (no
Inventor
Bruce Anthony Dressman
Marlys Hammond
Stephen Warren Kaldor
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO934721D0 publication Critical patent/NO934721D0/no
Publication of NO934721L publication Critical patent/NO934721L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det blir beskrevet en forbindelse med formel (I):. hvor. R og R° uavhengig er valgt blant hydrogen, ( C^- C^)alkyl, aryltC^)alkyl,. heterocyklus(C-C)alkyl eller umettet heterocvklus(C-C)alkyl; eller. R og R*1 er kombinert med nitrogenet til hvilket de er bundet for å danne en heterocyklus eller umettet heterocyklus med den forutsetning at nitrogen-atomet Ikke kan være kvaternlsert;. Z er en gruppe som har strukturen:. Rer hydrogen, halo, (Cy-C^alkyl, aryl( C^- C^)alkyl, (Cj-Cf,Jalkoksy, (Cj-Cfjjalkyltio, amino, (^-0)alkylamlno, di(C1-C4 )alkylamlno, karbamoyl eller N-(C1-C4 )alkylkarbamoyl;. rer aryl, heterocyklus, umettet heterocyklus, (C-^Jcykloalkyl eller -S-R, hvor Rer aryl, heterocyklus,. umettet heterocyklus eller (C5-C7 )cykloalkyl;. X er en gruppe som har strukturen:. eller et farmasøytisk akseptabelt salt av disse.Forbindelsen med formel (I) er hemmere av HIV-protease og er anvendelige i farmasøytisk formuleringer for behandling og/eller forhindring av HIV-infeksJon og/eller AIDS.
NO934721A 1992-12-22 1993-12-20 Hemmere av HIV-protease som er nyttige for behandling av AIDS NO934721L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99562192A 1992-12-22 1992-12-22

Publications (2)

Publication Number Publication Date
NO934721D0 NO934721D0 (no) 1993-12-20
NO934721L true NO934721L (no) 1994-06-23

Family

ID=25542022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934721A NO934721L (no) 1992-12-22 1993-12-20 Hemmere av HIV-protease som er nyttige for behandling av AIDS

Country Status (15)

Country Link
EP (1) EP0609625A1 (no)
JP (1) JPH06256277A (no)
KR (1) KR940014336A (no)
CN (1) CN1092410A (no)
AU (1) AU5252993A (no)
BR (1) BR9305161A (no)
CA (1) CA2112052A1 (no)
CO (1) CO4180513A1 (no)
CZ (1) CZ281393A3 (no)
FI (1) FI935780A7 (no)
HU (1) HUT69703A (no)
IL (1) IL108098A0 (no)
MX (1) MX9308025A (no)
NO (1) NO934721L (no)
PL (1) PL301578A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5747540A (en) * 1996-10-21 1998-05-05 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
AU2001252958A1 (en) 2000-03-23 2001-10-03 Elan Pharmaceuticals, Inc. Compounds and methods to treat alzheimer's disease
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US6846813B2 (en) 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2410680A1 (en) 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
AU7622500A (en) * 2000-09-29 2002-07-01 Neurogen Corp High affinity small molecule c5a receptor modulators
CA2452039A1 (en) 2001-06-27 2003-01-09 Elan Pharmaceuticals, Inc. Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
MXPA04000565A (es) * 2001-07-19 2005-06-17 Cv Therapeutics Inc Compuestos de piperazina sustituidos y su uso como inhibidores de oxidacion de acidos grasos.
CA2462851A1 (en) 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
US7262208B2 (en) 2002-04-30 2007-08-28 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of Alzheimer's disease
JP4721214B2 (ja) * 2004-09-14 2011-07-13 日本曹達株式会社 ピリジルメチルカルバミン酸エステル化合物及びピリジルメチルアミン化合物の製造方法
JP4698991B2 (ja) * 2004-09-14 2011-06-08 日本曹達株式会社 ピリジルメチルカルバミン酸エステル化合物、その製造方法及びピリジルメチルアミン化合物の製造方法
MX2007012341A (es) 2005-04-08 2008-02-12 Comentis Inc Compuestos que inhiben actividad beta-secretasa y metodos de uso de los mismos.
EP2307345A4 (en) * 2008-07-01 2012-05-02 Purdue Research Foundation NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
CN110872251A (zh) * 2019-11-28 2020-03-10 卡博金艾美斯医药(上海)有限公司 N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361341A3 (en) * 1988-09-28 1991-07-03 Miles Inc. Therapeutics for aids based on inhibitors of hiv protease
WO1991008221A1 (en) * 1989-12-04 1991-06-13 Wisconsin Alumni Research Foundation Peptide inhibitors of hiv protease
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives

Also Published As

Publication number Publication date
BR9305161A (pt) 1994-11-01
MX9308025A (es) 1994-08-31
JPH06256277A (ja) 1994-09-13
EP0609625A1 (en) 1994-08-10
HU9303677D0 (en) 1994-04-28
CN1092410A (zh) 1994-09-21
FI935780A7 (fi) 1994-06-23
IL108098A0 (en) 1994-04-12
CO4180513A1 (es) 1995-06-07
NO934721D0 (no) 1993-12-20
PL301578A1 (en) 1994-06-27
CZ281393A3 (en) 1994-07-13
FI935780A0 (fi) 1993-12-21
CA2112052A1 (en) 1994-06-23
AU5252993A (en) 1994-07-07
KR940014336A (ko) 1994-07-18
HUT69703A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
NO934719L (no) Hemmere av HIV-protease som er nyttige for behandling av AIDS
AU623733B2 (en) Benzofused-n-containing heterocyle derivatives
NZ505675A (en) N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents
NO954427L (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
NO905322L (no) Aminosyrederivater.
WO2002083111A3 (en) Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
DK0467248T3 (da) Pyrazolopyridinforbindelse og fremgangsmåder til fremstilling heraf
DK1142887T3 (da) 5,6-Dihydropyronderivater som proteaseinhibitorer og antivirale midler
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
FI915819A0 (fi) Hiv- proteas-inhibitorer.
SE0201194D0 (sv) New compounds
WO1995014011A3 (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
KR940014336A (ko) 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제
YU42893A (sh) Inhibitori hiv proteaze korisni za tretiranje aids-a
KR930002319A (ko) Aids 치료에 유용한 hiv 프로테아제의 억제제
CA2183234A1 (en) Agent for prophylaxis and treatment of thromboxane a2-mediated diseases
WO2000078793A3 (en) Antimicrobial agents
TH44626B (th) อนุพันธ์เฮเทอโรไซคลิคอะซาเฮกเซนที่ออกฤทธิ์ต่อต้านเชื้อไวรัส